Lista de obras - David K Wong - Dominio Público Uruguay

Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids

article

Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.

artículo científico publicado en 2010

Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial.

artículo científico publicado en 2014

Death from Liver Failure despite Lamivudine Prophylaxis during R-CHOP Chemotherapy due to Rapid Emergence M204 Mutations.

artículo científico publicado en 2013

Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B

artículo científico publicado en 2019

Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes.

artículo científico publicado en 2006

Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation.

artículo científico publicado en 2017

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

artículo científico publicado en 1993

Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.

artículo científico publicado en 2017

Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.

artículo científico publicado en 2012

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

article

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection

artículo científico publicado en 2016

HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection

artículo científico publicado en 2008

Health state utilities and quality of life in patients with hepatitis B.

artículo científico publicado en 2012

Hepatitis B Learning Needs Assessment of Family Medicine Trainees in Canada: Results of a Nationwide Survey ⬇️

artículo científico publicado el 1 de marzo de 2011

Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.

artículo científico publicado en 2015

Hepatitis C virus late relapse after sustained virologic response from interferon and ribavirin treatment as confirmed by RNA sequencing.

scientific article published on 30 October 2013

Hepatoma in hepatitis B: Infectious disease or liver disease?

artículo científico publicado en 2015

Hepatotoxicity and potential drug interaction with ledipasvir/sofosbuvir in HIV/HCV infected patients.

artículo científico publicado en 2016

Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population

artículo científico publicado en 1995

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

artículo científico publicado en 2015

Liver Failure After Abdominal Irradiation: Identifying the Right Suspects.

artículo científico publicado en 2014

Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.

artículo científico publicado en 1998

Missed opportunities for hepatocellular carcinoma screening in an HIV/hepatitis C virus-coinfected cohort.

artículo científico publicado en 2013

Non-Alcoholic Fatty Liver Disease in HIV Infection Associated with Altered Hepatic Fatty Acid Composition

article

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension

artículo científico publicado en 2019

Optimizing hepatitis C therapy in HIV/hepatitis C virus (HCV) coinfected patients: Analysis of HCV viral kinetics on treatment.

artículo científico publicado en 2012

Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C.

artículo científico publicado en 2010

Prevalence and risk factors for viral blipping in chronic hepatitis B patients treated with nucleos (t) ide analogues.

artículo científico publicado en 2016

Psychiatric treatment considerations with direct acting antivirals in hepatitis C ⬇️

artículo científico publicado el 14 de mayo de 2013

Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B

artículo científico publicado en 2015

Response-guided therapy for hepatitis C genotype 2 and 3 in those with HIV coinfection.

artículo científico publicado en 2014

Severe Acute Hepatitis B in HBV-Vaccinated Partner of a Patient with Multiple Myeloma Treated with Cyclophosphamide, Bortezomib, and Dexamethasone and Autologous Stem Cell Transplant

artículo científico publicado en 2017

Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C.

artículo científico publicado en 2010

Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.

artículo científico publicado en 2010

The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection

artículo científico publicado en 2015

Lista de obras de David K Wong

Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids

Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.

Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial.

Death from Liver Failure despite Lamivudine Prophylaxis during R-CHOP Chemotherapy due to Rapid Emergence M204 Mutations.

Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B

Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes.

Durability of Response After Hepatitis B Surface Antigen Seroclearance During Nucleos(t)ide Analogue Treatment in a Multiethnic Cohort of Chronic Hepatitis B Patients: Results After Treatment Cessation.

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

Efficacy and Safety of Direct Acting Antivirals for the Treatment of Mixed Cryoglobulinemia.

Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naïve patients with chronic hepatitis B.

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection

HIV-specific T-cells accumulate in the liver in HCV/HIV co-infection

Health state utilities and quality of life in patients with hepatitis B.

Hepatitis B Learning Needs Assessment of Family Medicine Trainees in Canada: Results of a Nationwide Survey ⬇️

Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.

Hepatitis C virus late relapse after sustained virologic response from interferon and ribavirin treatment as confirmed by RNA sequencing.

Hepatoma in hepatitis B: Infectious disease or liver disease?

Hepatotoxicity and potential drug interaction with ledipasvir/sofosbuvir in HIV/HCV infected patients.

Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

Liver Failure After Abdominal Irradiation: Identifying the Right Suspects.

Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.

Missed opportunities for hepatocellular carcinoma screening in an HIV/hepatitis C virus-coinfected cohort.

Non-Alcoholic Fatty Liver Disease in HIV Infection Associated with Altered Hepatic Fatty Acid Composition

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension

Optimizing hepatitis C therapy in HIV/hepatitis C virus (HCV) coinfected patients: Analysis of HCV viral kinetics on treatment.

Pegylated interferon plus optimized weight-based ribavirin dosing negate the influence of weight and body mass index on early viral kinetics and sustained virological response in chronic hepatitis C.

Prevalence and risk factors for viral blipping in chronic hepatitis B patients treated with nucleos (t) ide analogues.

Psychiatric treatment considerations with direct acting antivirals in hepatitis C ⬇️

Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B

Response-guided therapy for hepatitis C genotype 2 and 3 in those with HIV coinfection.

Severe Acute Hepatitis B in HBV-Vaccinated Partner of a Patient with Multiple Myeloma Treated with Cyclophosphamide, Bortezomib, and Dexamethasone and Autologous Stem Cell Transplant

Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C.

Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.

The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection